DRREDDY — Dr Reddy's Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Dr Reddy's Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	175,170	190,475	215,452	246,697	280,111
Cost of Revenue
Gross Profit	115,044	124,828	135,480	163,649	198,024
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	162,030	164,022	189,427	194,498	213,956
Operating Profit	13,140	26,453	26,025	52,199	66,155
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	18,857	28,835	30,614	60,485	72,010
Provision for Income Taxes
Net Income After Taxes	20,219	19,203	21,781	45,073	55,779
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	20,260	19,516	21,825	45,073	55,779
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	20,260	19,516	21,825	45,073	55,779
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	188	143	166	279	328
Dividends per Share